Eton Q

Manufacturer
Chong Kun Dang Pharm. Corp. | DongSung Pharm Co., Ltd.
Effective date
2021-07-12
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 23:41:22

Label at a glance#

ProductEton Q
Active ingredientZEA MAYS WHOLE
Label structure10 sections

Indications and uses

■ Adjuvant treatment for gingivitis ■ Mild/moderate periodontitis after periodontal treatment

Dosage and administration

■ Administration Adults: take orally. In initial, take 2 tablets three times per day before meals (on empty stomach). For maintenance, take 1 tablet three times a day in empty before meals (on empty stomach). Appropriately increase or decrease amount of administration according to your age and symptoms.

Label contents#

Full prescribing information#

ACTIVE INGREDIENT

OTC - ACTIVE INGREDIENT SECTION

Active ingredient (In each tablet)
ZEA MAYS WHOLE (Titrated Extract of Zea Mays L. Unsaponifiable Fraction)………………35.0mg (equal to 7mg β-sitosterol)

INACTIVE INGREDIENTS

INACTIVE INGREDIENT SECTION

Microcrystalline Cellulose, Corn Starch, Colloidal Silicon Dioxide, Povidone (K-30), Kaolin, Magnesium Stearate

PURPOSE

OTC - PURPOSE SECTION

Treatment for gingivitis and mild/moderate periodontitis

WARNINGS

WARNINGS SECTION

Do not use
■ If you are hypersensitive to Zea Mays L. or any of the inactive ingredients in this drug ■ Ask a doctor of pharmacist before use if you are applicable to following conditions: 1) Azo pigments; Use with caution in patients with hypersensitivity to acetylsalicylic acid or other prostaglandin synthase inhibitors.do. 2) Be careful as this drug may interfere with the absorption of cholesterol drugs. 3) Pregnant or likely to be pregnant. Women who are pregnant or are breast-feeding (the safety of administration during pregnancy has not been established, so pregnant or breast-feeding women who may be pregnant). For women, it is administered only when it is judged that the therapeutic benefit outweighs the risk.) 4) This drug contains Yellow No. 4(Atrazine), Yellow No. 5(Sunset Yellow FCF). Please, consult your doctor, dentist, or pharmacist before taking if you are hypersensitive or allergic any of the ingredients in this drug ■ In the following cases, stop taking this drug immediately and consult a doctor, dentist or pharmacist. Whenever possible, carry this information with you. 1) May cause mild laxative effects. 2) If this drug is administered to a patient with asthma, chronic urticaria, or hypersensitivity to nonsteroidal anti-inflammatory drugs, it may cause hypersensitivity to the skin or respiratory system. 3) As a result of a clinical trial conducted on patients with periodontal disease to evaluate the efficacy and safety of this drug in Korea, taking this drug (3 times a day for 4 weeks, 2 tablets at a time, 4 weeks to 12 weeks) The adverse reactions reported in 72 patients who took this drug 3 times a day, 1 tablet at a time, for a total of 12 weeks) were as follows, regardless of the causal relationship. Nasopharyngitis (2 cases), dental abscess (pus), abdominal pain (belly pain), tooth fracture, AST increase, ALT increase, glaucoma, hyperlipidemia, pain in limbs, tooth extraction (extraction) (1 case each). 4) If there is no improvement in symptoms even after taking it for more than 1 month.■ Other precautions when taking this drug. 1) Be sure to follow the prescribed usage and dosage. 2) Do not take this drug continuously for a long time.

KEEP OUT OF REACH OF CHILDREN

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

NA

Uses

INDICATIONS & USAGE SECTION

■ Adjuvant treatment for gingivitis
■ Mild/moderate periodontitis after periodontal treatment

Directions

DOSAGE & ADMINISTRATION SECTION

■ Administration
Adults: take orally. In initial, take 2 tablets three times per day before meals (on empty stomach). For maintenance, take 1 tablet three times a day in empty before meals (on empty stomach). Appropriately increase or decrease amount of administration according to your age and symptoms.

Other Information

OTHER SAFETY INFORMATION

■ Storage at room temperature between 1~30℃ (33.8~86.0 °F) ■ Do not use if carton is opened ■ Do not use if foil inner seal is broken or missing ■ Keep out of reach of children ■ Store at a cool and dry place, away from direct sunlight and high temperature ■ Taking drugs out of their original containers and storing them in other containers may cause misuse or deterioration of drugs, therefore, put them in the original containers and keep them tightly closed.

QUESTIONS

OTC - QUESTIONS SECTION

■ Call +82-080-6776-080 ■ Website: www.ckdpharm.com

PACKAGE LABEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Image of cartonImage of carton

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
82024-010-012022-07-29C16284748780-1e4f33bdf-9c59-d8a0-e053-dadaa90a6e4e4b029515-9a49-4218-95bd-caad9c67bafe

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
82024-010-01Eton Q270 in 1 CARTONTABLET2701

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
82024-010ETON Q (ZEA MAYS WHOLE) TABLET [CHONG KUN DANG PHARM. CORP.]1Legacy NDC, 1 package rows20210713_4b029515-9a49-4218-95bd-caad9c67bafe.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 8 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
82024-01082024-010-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 7 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
8c34d418-1757-495d-b7c7-fae57df5f4514b029515-9a49-4218-95bd-caad9c67bafe2021-07-12WarningsExact identifier
spl id: 8c34d418-1757-495d-b7c7-fae57df5f451
spl set id: 4b029515-9a49-4218-95bd-caad9c67bafe

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.